[1] Benedict M, Zhang X.Non-alcoholic fatty liver disease: An expanded review.World J Hepatol. 2017;9:715-732.
[2] Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, et al.The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.Hepatology .2018;67:328-357.
[3] Dai W, Ye L, Liu A, Wen SW, Deng J, et al.Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: A meta-analysis.Medicine. 2017;96:8179-8186.
[4] Bril F, Cusi K. Management of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Call to Action.Diabetes Care.2017; 40:419-430.
[5] Angulo P, Hui JM, Marchesini G, Bugianesi E, George J, et al.The NAFLD fibrosis score: a noninvasive system that identifies live fibrosis in patients with NAFLD.Hepatology .2007;45:846-854.
[6] Stefan N, Kantartzis K, Hringhu HU.Causes and metabolic consequence of fatty liver.Endocr Rev .2008;29:939-960.
[7] Zhang Linshan, Bian Hua, Yan Hongmei, Xia Mingfeng, Chang Xinxia, et al.Study on the correlation between liver fat content and liver disease outcomes in type 2 diabetes mellitus.Chin J Endocrinol Metab .2014;30:3-7 (In Chinese).
[8] Byrne CD, Targher G. NAFLD: a multisystem disease. J Hepatol .2015;62:47–64.
[9] Lee KW, Bang KB, Rhee EJ, Kwon HJ, Lee MY, et al.Impact of hypothyroidism on the development of non-alcoholic fatty liver disease: a 4-year retrospective cohort study.Clin Mol Hepatol .2015;21: 372-378.
[10] Van den berg EH, Van Tienhoven-Wind LJ, Amini M, Schreuder TC, Faber KN, et al.Higher free triiodothyonine is associated with non-alcoholic fatty liver disease in euthyroid subjects: the Lifelines Cohort Study.Metabolism.2017;67:62-71.
[11] Kim D, Kim W, Joo SK, Bae JM, Kim JH, et al.Subclinical
Hypothyroidism and Low-Normal Thyroid Function are Associated with Nonalcoholic Steatohepatitis and Fibrosis.Clin Gastroenterol Hepatol.2018;16:123-
[12] Bril F, Kadiyala S, Portillo Sanchez P, Sunny NE, Biernacki D, et al. Plasma thyroid hormone concentration is associated with hepatic triglyceride contentin patients with type 2 diabetes. J Investig Med.2016;64:63-68.
[13] Fan J.Guide to diagnosis and treatment of non-alcoholic fatty liver disease in China (revised edition 2010). China Medical Frontier Magazine (Electronic).2012;7: 4-10.
[14] Li X, Zhou Z, Qi H,Chen X,Huang G.Replacement of insulin by fasting C-peptide in modified homeostasis model assessment to evaluate insulin resistance and islet β cell function. J Cent South Univ (Med Sci) .2004;29:419-423 (In Chinese).
[15] Bano A, Chaker L, Plompen EP, Hofman A, Dehghan A, et al. Thyroid function and the risk of non-Alcoholic fatty liver disease: The Rotterdam Study. J Clin Endocrinol Metab.2016;101:3204-3211.
[16] Liu G, Zheng X, Guan L, Jiang Z, Lin H, et al.Free triiodothyronine levels are positively associated with non-alcoholic fatty liver disease in euthyroid middle-aged subjects. Endocr Res.2015;40:188-193.
[17] Fuchs CD, Claudel T, Trauner M.Role of metabolic lipases and lipolytic metabolites in the pathogenesis of NAFLD. Trends Endocrinol Metab.2014;25:576–
585.
[18] Yu H, Yang Y, Zhang M, Lu H, Zhang J, et al.Thyroid status influence on adiponectin, acylation stimulating protein (ASP) and complement C3 in hyperthyroid and hypothyroid subjects. Nutr Metab (Lond) .2006;3:13-20.
[19] Musso G, Gambino R, Durazzo M, Biroli G, Carello M, et al.Adipokines in NASH: postprandial lipid metabolism as a link between adiponectin and liver disease. Hepatology .2005;42:1175–1183.
[20] Wang L, Hao L, Yang W, Li Y, Peng X, et al. Study on levels of serum thyroid hormone and relations between it and hepatic fibrosis in non-alcoholic fatty liver disease patients. J Prac Med.2011;27:3874-3876 (In Chinese).
[21] Liu Y, Wang W, Yu X, Qi X.Thyroid Function and Risk of Non-Alcoholic Fatty Liver Disease in Euthyroid Subjects[J]. Ann Hepatol.2018; 17:779-788.
[22] Kim D, Yoo ER, Li AA, Fernandes CT, Tighe SP, et al.Low-Normal Thyroid Function Is Associated With Advanced Fibrosis Among Adults in the United States. Clin Gastroenterol Hepatol .2018;3565:31267-31269.
[23] Chen J, Zhou X, Liu Y, Hu P, Ji L, et al.Associated factors of high non-alcohol fatty liver disease fibrosis score in hospitalized patients with type 2 diabetes. Chin J Diabetes.2017;25:980-984.
[24] Portillo-Sanchez P, Bril F, Maximos M, Lomonaco R, Biernacki D, Orsak B, et al.High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels.J Clin Endocrinol Metab.2015;100(6):2231-8.
[25] Zhu Fanfan,Yang Lizhen.Correlation between the levels of serum thyroid hormones and non-alcoholic fatty liver disease in euthyroid type 2 diabetic patients.J Shanghai Jiao Tong Univ.2018;38:763-768.
[26] Lonardo A, Mantovani A, Lugari S, Targher G.NAFLD in Some Common Endocrine Diseases: Prevalence, Pathophysiology, and Principles of Diagnosis and Management.Int J Mol Sci.2019;20(11). pii: E2841.
[27] Chung GE,Kim D,Kim W,Yim JY,Park MJ,et al.Non-alcoholic fatty liver disease across the spectrum of hypothyroidism. J Hepatol.2012;57(1):150-156.
[28] Park YJ,Lee YJ,Choi SI,Chun EJ,Jang HC,et al.Impact of subclinical hypothyroidism on the coronary artery disease in apparently healthy subjects.Eur J Endocrinol.2011;165(1):115-121.
[29] Carulli L,Ballestri S,Lonardo A,Lami F,Violi E,et al.Is nonalcoholic steatohepatitis associated with a high -though -normal thyroid stimulating hormone level and lower cholesterol levels?. Intern Emerg Med.2013;8(4):297-305.
[30] Ittermann T,Haring R,Wallaschofski H,Baumeister SE,Nauck M,et al.Inverse association between serum free thyroxine levels and hepatic steatosis:results from the study of health in Pomerania. Thyroid.2012;22(6):568-574.